{"disease":{"id":"second-degree-burn","name":"second degree burn"},"drugs":{"marketed":[{"drug_id":"mafenide","indication_name":"Adjunctive therapy for second- and third-degree burns","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sulfamylon","generic_name":"MAFENIDE","company_name":"Rising","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 12","drug_class":"Methylated Sulfonamide Antibacterial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"silver","indication_name":"second degree burns","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Silver Sulfadiazine","generic_name":"SILVER","company_name":"King Pharms Llc","drug_phase":"marketed","molecular_target":"","drug_class":"Sulfonamide Antibacterial [EPC]","quality_score":38,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07300137","title":"Comparison of Amniotic Membrane Dressing and Aquacel®Ag in Second-degree Burns","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100,"lead_sponsor_name":"Patel Hospital, Pakistan","has_results":false},{"nct_id":"NCT04124133","title":"Evaluation of Efficacy and Safety of Ialuset Cream and Gauze in Second-degree Burns on Child","phase":"","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"Laboratoires Genévrier","has_results":false},{"nct_id":"NCT06263296","title":"Smartphone Assisted Self-management Education for Adult Burn Patient At Aftercare","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Queen Mary Hospital, Hong Kong","has_results":false},{"nct_id":"NCT06103409","title":"MSCs for the Treatment of Burn Wounds","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Instituto Venezolano de Investigaciones Cientificas","has_results":false},{"nct_id":"NCT04685577","title":"Safety, Tolerability and Efficacy of Nefopam Cream in Burn Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"University of Alberta","has_results":false},{"nct_id":"NCT06170008","title":"Efficacy of a Transparent Silicone Membrane With Physical Microstructure for Second-degree Burn Wounds and Skin Graft Wounds","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT07453732","title":"Banana Leaves as a Wound Dressing for Partial Thickness Second Degree Burns in Adult Patients.","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT03113747","title":"Allogeneic ADSCs and Platelet-Poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds (ADSCs-BWs)","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"A.A. Partners, LLC","has_results":false},{"nct_id":"NCT04890574","title":"CellMist™ Autologous Cells to Treat Deep Second-Degree Burns","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":14,"lead_sponsor_name":"RenovaCare, Inc","has_results":false},{"nct_id":"NCT03530150","title":"Pirfenidone and Its Role in Burn Wound Healing","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Universidad Autonoma de Nuevo Leon","has_results":false},{"nct_id":"NCT04149808","title":"Mepilex Ag vs. Xeroform in Pediatric Patients That Sustain Partial Thickness Burn Injury","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Wayne State University","has_results":false},{"nct_id":"NCT04684121","title":"Study of the Efficacy and Safety of Granexin® Gel to Improve Burn Wound Healing","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Xequel Bio, Inc.","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}